Evidence map›Paper›PMID 9350301›Full record

Trial reportMolecular pathology : MP1997

A two year prospective study to compare culture and polymerase chain reaction amplification for the detection and diagnosis of Lyme borreliosis.

M M Picken, R N Picken, D Han, Y Cheng, E Ruzic-Sabljic, J Cimperman, V Maraspin, S Lotric-Furlan, F Strle

Abstract readClinical TrialComparative StudyControlled Clinical Trial
In one paragraph

Trial report in Molecular pathology : MP, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Laboratory Diagnosis of Lyme Borreliosis.Clinical microbiology reviews · 2021
    Review
  4. Article
  5. Laboratory diagnosis of Lyme disease: advances and challenges.Infectious disease clinics of North America · 2015
    Review
  6. Review
  7. Article
  8. Article
  9. Diagnosis of lyme borreliosis.Clinical microbiology reviews · 2005
    Review
  10. Article
  11. Article
  12. Lyme disease: an update.Current allergy and asthma reports · 2001
    Review
  13. Evaluation of a new culture medium for Borrelia burgdorferi.Journal of clinical microbiology · 2000
    Article
  14. Article
  15. Diagnostic value of PCR for detection of Borrelia burgdorferi DNA in clinical specimens from patients with erythema migrans and Lyme neuroborreliosis.Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology · 2000
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

M M PickenDepartment of Pathology, Loyola University Medical Center, Maywood, IL, USA.
R N Picken
D Han
Y Cheng
E Ruzic-Sabljic
J Cimperman
V Maraspin
S Lotric-Furlan
F Strle

Funding

LYME DISEASE DIAGNOSIS BY PCR/DNA PROBE SYSTEMR01AR041517 · NIAMS · RUSH UNIVERSITY · PI PICKEN, ROGER N · 1991 to 1994
–
NIAMS NIH HHS AR 41517
6 · The paper itself

Abstract

aimTo compare polymerase chain reaction (PCR) amplification of borrelial DNA and culture isolation of spirochaetes for the diagnosis of Lyme borreliosis by direct detection of Borrelia burgdorferi sensu lato in patients with erythema migrans and acrodermatitis chronica atrophicans lesions.

methodsSkin biopsy specimens from erythema migrans and acrodermatitis chronica atrophicans lesions were subdivided and tested by PCR amplification assay and culture using two artificial growth media, Barbour-Stoenner-Kelly II (BSK II) and modified Kelly-Pettenkofer (MKP). Five classes of lesions were studied: typical erythema migrans, spontaneously resolved erythema migrans, atypical/partially treated erythema migrans, typical acrodermatitis chronica atrophicans, and atypical/partially treated acrodermatitis chronica atrophicans.

resultsFor both erythema migrans and acrodermatitis chronica atrophicans lesions, the most sensitive detection method was MKP culture. PCR was less sensitive than MKP culture, but more sensitive than BSK II culture. Results for 758 typical erythema migrans specimens showed positivity rates of 36% for MKP, 25% for PCR, and 24% for BSK II. Differences were statistically significant. The overall positivity rate for all three methods combined was 54%, but few specimens (6%) were positive by all three methods. Examination of multiple erythema migrans lesions from the same patient increased the diagnostic yield. These findings, and similar results for acrodermatitis chronica atrophicans lesions, suggest that the distribution of spirochaetes in skin biopsies is not homogeneous.

conclusionsAlthough possessing the potential to provide a rapid diagnosis, PCR is not more sensitive than culture for the direct detection of borrelia. Spirochaetes appear to be unevenly distributed throughout biopsy specimens, suggesting that diagnosis of Lyme borreliosis by direct detection of the causative agent in skin lesions in vulnerable to sample bias.

Indexed as

AcrodermatitisBacteriological TechniquesBorrelia burgdorferi GroupCulture MediaDNA, BacterialErythema Chronicum MigransHumansLyme DiseasePolymerase Chain ReactionProspective StudiesSkinCulture MediaDNA, Bacterial

Identifiers

PMID9350301
PMCPMC379624

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.